FDA Supplement Guidance Likely To Remain Onerous, Attys Say
The U.S. Food and Drug Administration's decision to revise draft guidance that would increase the burden on dietary supplement makers to prove a product's safety may seem like a win for...To view the full article, register now.
Already a subscriber? Click here to view full article